Show simple item record

dc.contributor.authorChen, Ming-Hueien_US
dc.contributor.authorLarson, Martin G.en_US
dc.contributor.authorHsu, Yi-Hsiangen_US
dc.contributor.authorPeloso, Gina M.en_US
dc.contributor.authorGuo, Chao-Yuen_US
dc.contributor.authorFox, Caroline S.en_US
dc.contributor.authorAtwood, Larry D.en_US
dc.contributor.authorYang, Qiongen_US
dc.date.accessioned2012-01-11T15:51:11Z
dc.date.available2012-01-11T15:51:11Z
dc.date.copyright2010
dc.date.issued2010-5-14
dc.identifier.citationChen, Ming-Huei, Martin G Larson, Yi-Hsiang Hsu, Gina M Peloso, Chao-Yu Guo, Caroline S Fox, Larry D Atwood, Qiong Yang. "A three-stage approach for genome-wide association studies with family data for quantitative traits" BMC Genetics 11:40. (2010)
dc.identifier.issn1471-2156
dc.identifier.urihttps://hdl.handle.net/2144/3070
dc.description.abstractBACKGROUND. Genome-wide association (GWA) studies that use population-based association approaches may identify spurious associations in the presence of population admixture. In this paper, we propose a novel three-stage approach that is computationally efficient and robust to population admixture and more powerful than the family-based association test (FBAT) for GWA studies with family data. We propose a three-stage approach for GWA studies with family data. The first stage is to perform linear regression ignoring phenotypic correlations among family members. SNPs with a first stage p-value below a liberal cut-off (e.g. 0.1) are then analyzed in the second stage that employs a linear mixed effects (LME) model that accounts for within family correlations. Next, SNPs that reach genome-wide significance (e.g. 10-6 for 34,625 genotyped SNPs in this paper) are analyzed in the third stage using FBAT, with correction of multiple testing only for SNPs that enter the third stage. Simulations are performed to evaluate type I error and power of the proposed method compared to LME adjusting for 10 principal components (PC) of the genotype data. We also apply the three-stage approach to the GWA analyses of uric acid in Framingham Heart Study's SNP Health Association Resource (SHARe) project. RESULTS. Our simulations show that whether or not population admixture is present, the three-stage approach has no inflated type I error. In terms of power, using LME adjusting PC is only slightly more powerful than the three-stage approach. When applied to the GWA analyses of uric acid in the SHARe project of FHS, the three-stage approach successfully identified and confirmed three SNPs previously reported as genome-wide significant signals. CONCLUSIONS. For GWA analyses of quantitative traits with family data, our three-stage approach provides another appealing solution to population admixture, in addition to LME adjusting for genetic PC.en_US
dc.description.sponsorshipNational Heart, Lung and Blood Institute's Framingham Heart Study (N01-HC-25195); Affymetrix, Inc (N02-HL-6-4278); Boston University School of Medicine & Boston Medical Center (Robert Dawson Evans Endowment)en_US
dc.language.isoen
dc.publisherBioMed Centralen_US
dc.rightsCopyright 2010 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.0
dc.titleA Three-Stage Approach for Genome-Wide Association Studies with Family Data for Quantitative Traitsen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/1471-2156-11-40
dc.identifier.pmid20470424
dc.identifier.pmcid2892427


This item appears in the following Collection(s)

Show simple item record

Copyright 2010 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as Copyright 2010 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.